Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism
Nermin Eissa, Petrilla Jayaprakash, Sheikh Azimullah, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

A standardized social preference protocol for measuring social deficits in mouse models of autism
Benjamin Rein, Kaijie Ma, Zhen Yan
Nature Protocols (2020) Vol. 15, Iss. 10, pp. 3464-3477
Open Access | Times Cited: 153
A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism
Devahuti R. Chaliha, Matthew A. Albrecht, Mauro Vaccarezza, et al.
Developmental Neuroscience (2020) Vol. 42, Iss. 1, pp. 12-48
Open Access | Times Cited: 124
Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder
Anna Maria Tartaglione, Sara Schiavi, Gemma Calamandrei, et al.
Neuropharmacology (2019) Vol. 159, pp. 107477-107477
Closed Access | Times Cited: 93
Histamine, Neuroinflammation and Neurodevelopment: A Review
Elliott Carthy, Tommas J. Ellender
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 80
Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Nermin Eissa, Adel Sadeq, Astrid Sasse, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 75
Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
Abdoh Taleb, Wen Lin, Xiang Xu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111322-111322
Open Access | Times Cited: 65
Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics
Junbin Tian, Xuping Gao, Li Yang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 58
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder
Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 831-831
Open Access | Times Cited: 9
Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats
Roohi Mirza, Bhupesh Sharma
Brain Research Bulletin (2019) Vol. 147, pp. 36-46
Closed Access | Times Cited: 64
The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice
Nermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
Chemico-Biological Interactions (2019) Vol. 312, pp. 108775-108775
Closed Access | Times Cited: 55
Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders
Annalisa Savardi, Marco Borgogno, Roberto Narducci, et al.
Chem (2020) Vol. 6, Iss. 8, pp. 2073-2096
Open Access | Times Cited: 53
The impact of glutathione metabolism in autism spectrum disorder
Geir Bjørklund, Monica Daniela Doşa, Michaël Maes, et al.
Pharmacological Research (2021) Vol. 166, pp. 105437-105437
Closed Access | Times Cited: 50
Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder
Hsiao‐Ying Kuo, Fu‐Chin Liu
Biomedicines (2022) Vol. 10, Iss. 3, pp. 560-560
Open Access | Times Cited: 28
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
David Zárate-López, Ana Laura Torres-Chávez, Alma Y. Gálvez‐Contreras, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 2, pp. 260-289
Open Access | Times Cited: 19
Beneficial effects of pioglitazone, a selective peroxisome proliferator‐activated receptor‐γ agonist in prenatal valproic acid‐induced behavioral and biochemical autistic like features in Wistar rats
Roohi Mirza, Bhupesh Sharma
International Journal of Developmental Neuroscience (2019) Vol. 76, Iss. 1, pp. 6-16
Closed Access | Times Cited: 49
The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice
Nermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3996-3996
Open Access | Times Cited: 39
Influence of Prenatal Drug Exposure, Maternal Inflammation, and Parental Aging on the Development of Autism Spectrum Disorder
Atsushi Sato, Hiroko Kotajima‐Murakami, Miho Tanaka, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 24
Mitigating effects of H3 receptor antagonism on cerebellar autophagic pathways and behavioral phenotypes in BTBR T+ tf/J mouse model of autism spectrum disorder
Nermin Eissa, Petrilla Jayaprakash, Shouq Aljneibi, et al.
European Journal of Pharmacology (2025), pp. 177481-177481
Open Access
Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models
Hsiao‐Ying Kuo, Fu‐Chin Liu
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 46
Simultaneous Blockade of Histamine H3 Receptors and Inhibition of Acetylcholine Esterase Alleviate Autistic-Like Behaviors in BTBR T+ tf/J Mouse Model of Autism
Nermin Eissa, Petrilla Jayaprakash, Holger Stark, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1251-1251
Open Access | Times Cited: 33
An acetylcholinesterase inhibitor, donepezil, increases anxiety and cortisol levels in adult zebrafish
Ana CVV Giacomini, Barbara W. Bueno, Leticia Marcon, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 12, pp. 1449-1456
Closed Access | Times Cited: 32
Excitatory and Inhibitory Synaptic Imbalance Caused by Brain-Derived Neurotrophic Factor Deficits During Development in a Valproic Acid Mouse Model of Autism
Chuchu Qi, Andi Chen, Honghui Mao, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 21
Cell-type-specific disruption of cortico-striatal circuitry drives repetitive patterns of behavior in fragile X syndrome model mice
Francesco Longo, Sameer Aryal, Paul G. Anastasiades, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112901-112901
Open Access | Times Cited: 11
Modeling the quantitative nature of neurodevelopmental disorders using Collaborative Cross mice
Remco T. Molenhuis, Hilgo Bruining, Myrna J. V. Brandt, et al.
Molecular Autism (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Antagonism of Histamine H3 receptors Alleviates Pentylenetetrazole-Induced Kindling and Associated Memory Deficits by Mitigating Oxidative Stress, Central Neurotransmitters, and c-Fos Protein Expression in Rats
Alaa Alachkar, Sheikh Azimullah, Mohamed Lotfy, et al.
Molecules (2020) Vol. 25, Iss. 7, pp. 1575-1575
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top